WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-7.04 Cr | ₹-5.50 Cr | ₹-5.50 Cr | ₹-5.63 Cr | ₹-5.63 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WANBURY ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-7.04 Cr |
| Mar2024 | ₹-5.50 Cr |
| Mar2023 | ₹-5.50 Cr |
| Mar2022 | ₹-5.63 Cr |
| Mar2021 | ₹-5.63 Cr |
How is Deferred Tax Assets / Liabilities of WANBURY Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-7.04 Cr | Negative | |
| Mar2024 | ₹-5.50 Cr | Negative | |
| Mar2023 | ₹-5.50 Cr | Negative | |
| Mar2022 | ₹-5.63 Cr | Negative | |
| Mar2021 | ₹-5.63 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹892.2 Cr | -4.7% | -13.3% | -11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹469,310.0 Cr | 2% | -1.7% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹245,426.0 Cr | 6.5% | 14.8% | 48.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,347.0 Cr | 1.2% | -2.5% | 37.2% | Stock Analytics | |
| CIPLA | ₹114,393.0 Cr | -0.3% | -3.9% | -11.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,240.2 Cr | -2.2% | 1.5% | -8.3% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -4.7% |
-13.3% |
-11.1% |
| SENSEX | -0.5% |
-1.3% |
-5.4% |
You may also like the below Video Courses